Results
|
1.
|
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung. MedStar authors:
Year: 2021
Citation: - Journal for Immunotherapy of Cancer. 9(2), 2021 02.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Bar J, Dudnik E, Gottfried T, Israel Lung Cancer Group, Kareff S, Kim C, Liu SV, Lobachov A, Moskovitz M, Onn A, Rotem O, Urban D, Wollner M, Zer A
|
|
2.
|
|
|
3.
|
|
|
4.
|
Publication rate of registered clinical trials in lung cancer. MedStar authors:
- Al-Shbool, Ghassan
- Farid, Saira
- Kim, Chul
- Latif, Hira
Year: 2019
Department: - MedStar Georgetown University Hospital Residents
All authors: - Al-Shbool G, Latif H, Farid S, Yin A, Ahn J, Giaccone G, Kim C.
|
|
5.
|
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection. MedStar authors:
- Al-Shbool, Ghassan
- Belouali, Anas
- Blackburn, Matthew
- Cook, Michael
- Kim, Chul
Year: 2019
Citation: - Journal for Immunotherapy of Cancer. 7(1):353, 2019 Dec 17.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Medicine/Internal Medicine
Medline publication type:
All authors: - Al-Shbool G, Atkins MB, Belouali A, Blackburn M, Cook M, Gibney GT, He AR, Kim C, Liu SV, Madhavan S, Shah NJ
|
|
6.
|
Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer. MedStar authors:
- Chen, Kevin
- Kim, Chul
- Peravali, Monica
- Rao, Suman
- Veytsman, Irina
Year: 2021
Citation: - Oncologist. 26(8):694-700, 2021 08.
Institution:
- MedStar Franklin Square Medical Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Hematology/Oncology Fellowship
Medline publication type:
All authors: - Ahn J, Chen K, Kim C, Liu SV, Peravali M, Rao S, Veytsman I
|
|
7.
|
Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients with HIV, hepatitis B, or hepatitis C viral infections. MedStar authors:
- Al-Shbool, Ghassan
- Blackburn, Matthew
- Cook, Michael
- Kelly, William J
- Kim, Chul
- Mohebtash, Mahsa
- Ochoa, Sebastian
- Serzan, Michael T
Year: 2019
Department: - MedStar Georgetown University Hospital Residents
All authors: - Shah NJ, Al-Shbool G, Blackburn M, Cook M, Kelly W, Ochoa S, Serzan M...[Mohebtash M, Kim C], et al.
|